单位：[1]Gene Therapy Center and the Institute of Hypertension Internal Medicine Department & Cardiovascular Division Department of Internal Medicine Tongji Hospital,Tongji Medical College Huazhong University of Science and Technology大内科高血压病研究所华中科技大学同济医学院附属同济医院内科学系心血管内科内科门诊[2]Cardiovascular Division Department of Internal Medicine, 161 Hospital of PLA
第一作者单位：[1]Gene Therapy Center and the Institute of Hypertension Internal Medicine Department & Cardiovascular Division Department of Internal Medicine Tongji Hospital,Tongji Medical College Huazhong University of Science and Technology[2]Cardiovascular Division Department of Internal Medicine, 161 Hospital of PLA
推荐引用方式(GB/T 7714)：
Huang Wei,Wen Wang Dao.MiRNA-320a in exacerbating non-alcoholic fatty liver disease (NAFLD) by undermining mitochondrial homeostasis via inhibition of PGC-1a[J].JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY.2018,72(16):C11-C11.doi:10.1016/j.jacc.2018.08.044.
APA：
Huang, Wei&Wen, Wang Dao.(2018).MiRNA-320a in exacerbating non-alcoholic fatty liver disease (NAFLD) by undermining mitochondrial homeostasis via inhibition of PGC-1a.JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY,72,(16)
MLA：
Huang, Wei,et al."MiRNA-320a in exacerbating non-alcoholic fatty liver disease (NAFLD) by undermining mitochondrial homeostasis via inhibition of PGC-1a".JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY 72..16(2018):C11-C11
医学